Skip to content

Effectiveness and occurence of adverse events of Medical Flossing in patients with shoulder disorders - a randomized controlled pilot trial

Effectiveness and occurence of adverse events of Medical Flossing in patients with shoulder disorders - a randomized controlled pilot trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012747
Enrollment
10
Registered
2018-01-15
Start date
2017-10-16
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M75.0 M75.1 M75.3 M75.4 M75.8 M75.9 M79.61 M79.81 M79.91 M19.01 M19.11 M24.51

Interventions

Group 1: Physical therapy routine care in combination with Medical Flossing (3 weeks, 2 treatments per week) Group 2: Physical therapy routine care in combination with sham Medical Flossing (3 weeks,

Sponsors

Hochschule für Gesundheit Department für GesundheitswissenschaftenStudiengang Physiotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Shoulder pain and/or loss of range of motion, fluent German language

Exclusion criteria

Exclusion criteria: • Tumors / metastases in the shoulder area • lymphedema around the shoulder • Inflammation marks around the shoulder • Thrombosis Vascular diseases in the arm (e.g., PAOD, varices) • decompensated heart failure (NYHA III, NYHA IV) • Taking anticoagulants • Taking cortisone • Pregnancy • skin diseases in the area of the shoulder (for example atopic dermatitis, psoriasis) • Skin damage / wounds around the shoulder • Nerve lesion around the shoulder / armpit • Condition after shoulder luxation within the last 6 weeks • Condition after shoulder surgery within the last 4 weeks without release of stress or movement

Design outcomes

Primary

MeasureTime frame
Disabilities of the Arm, Shoulder and Hand (DASH) at inclusion, before third treatment session and after the last treatment session

Secondary

MeasureTime frame
Pain (NRS), Range of motion (Goniometer), patient-reported overall treatment effect and adverse events using a self developed questionnaire. Time of data aquisition: at inclusion, before third treatment session and after the last treatment session.

Countries

Germany

Contacts

Public ContactChristian Kopkow

Hochschule für Gesundheit Department für GesundheitswissenschaftenStudiengang Physiotherapie

christian.kopkow@hs-gesundheit.de+49 234 77727624

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026